📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Modis Therapeutics

1.1 - Company Overview

Modis Therapeutics Logo

Modis Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of disease-modifying therapies to patients with rare genetic diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Modis Therapeutics

enGene Logo

enGene

HQ: Canada Website
  • Description: Provider of biotechnological treatments for mucosal diseases by inducing therapeutic proteins.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full enGene company profile →
Translate Bio Logo

Translate Bio

HQ: United States Website
  • Description: Provider of biotechnology-driven RNA therapeutics focused on rare diseases, developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Translate Bio company profile →
Gentris Logo

Gentris

HQ: United States Website
  • Description: Provider of global pharmacogenomic testing and biorepository services, helping pharmaceutical companies and clinical research organizations integrate pharmacogenomics into drug development to deliver safer, more effective compounds to market more quickly.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Gentris company profile →
GeneCentric Therapeutics Logo

GeneCentric Therapeutics

HQ: United States Website
  • Description: Provider of molecular diagnostic tests and RNA-based informatics for oncology, including rT(I)ME Explorer for therapy-selective gene signatures, PurIST for PDAC subtyping, FGFR-PRS for identifying FGFR inhibitor candidates in urothelial cancer, AF-PRS for NSCLC chemotherapy prognosis, ICI-PRS for immune checkpoint inhibitor response prediction, and rADIO for antigen discovery and immunotherapy biomarkers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GeneCentric Therapeutics company profile →
NXT-Dx Logo

NXT-Dx

HQ: Belgium Website
  • Description: Provider of epigenetics services from a private company led by an experienced team combining skills in epigenetics, transcriptomics, proteomics, and bioinformatics research.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NXT-Dx company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Modis Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Modis Therapeutics

2.2 - Growth funds investing in similar companies to Modis Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Modis Therapeutics

4.2 - Public trading comparable groups for Modis Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Modis Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Modis Therapeutics

What does Modis Therapeutics do?

Modis Therapeutics is a provider of disease-modifying therapies to patients with rare genetic diseases.

Who are Modis Therapeutics's competitors?

Modis Therapeutics's competitors and similar companies include enGene, Translate Bio, Gentris, GeneCentric Therapeutics, and NXT-Dx.

Where is Modis Therapeutics headquartered?

Modis Therapeutics is headquartered in United States.

How many employees does Modis Therapeutics have?

Modis Therapeutics has 1,000 employees 🔒.

When was Modis Therapeutics founded?

Modis Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Modis Therapeutics in?

Modis Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Modis Therapeutics

Who are the top strategic acquirers in Modis Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Modis Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Modis Therapeutics?

Top strategic M&A buyers groups and sectors for Modis Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Modis Therapeutics's sector and industry vertical

Which are the top PE firms investing in Modis Therapeutics's sector and industry vertical?

Top PE firms investing in Modis Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Modis Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Modis Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Modis Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Modis Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Modis Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Modis Therapeutics?

The key public trading comparables and valuation benchmarks for Modis Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Modis Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Modis Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Modis Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Modis Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Modis Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Modis Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Modis Therapeutics